ArticleTrials2021

Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial.

Deonna M Ackermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.